CAPSIDA
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.
CAPSIDA
Social Links:
Industry:
Biotechnology Genetics Health Care
Founded:
2019-01-01
Address:
Newbury Park, California, United States
Country:
United States
Website Url:
http://www.capsida.com
Total Employee:
11+
Status:
Active
Total Funding:
140 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Color
Color is a complete platform for healthcare delivery.
Current Advisors List
Current Employees Featured
Founder
Investors List
Westlake Village BioPartners
Westlake Village BioPartners investment in Series A - Capsida
Versant Ventures
Versant Ventures investment in Series A - Capsida
AbbVie
AbbVie investment in Corporate Round - Capsida
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-07 | Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO |
Official Site Inspections
http://www.capsida.com
- Host name: 70.35.200.219
- IP address: 70.35.200.219
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Capsida"
Capsida - Crunchbase Company Profile & Funding
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target …See details»
About - Capsida Biotherapeutics
Capsida’s AAV gene therapy platform originated from groundbreaking research in the laboratory of Professor Viviana Gradinaru, Ph.D. at Caltech. Professor Gradinaru’s lab is where Nick Goeden, Ph.D., then a post-doctoral researcher, …See details»
Capsida Company Profile | Management and Employees List
Capsida Profile and History Founded in 2019, based out of Thousand Oaks, CA, Capsida Biotherapeutics Inc. is developing tissue-targeted gene therapies using its biologically driven, …See details»
Capsida Biotherapeutics Poised to Capitalize on Industry-leading …
Dec 7, 2021 Longtime industry executive Peter Anastasiou appointed Chief Executive Officer Capsida co-founders Nicholas Flytzanis, Ph.D., promoted to Chief Scientific Officer and Nick …See details»
Capsida - Company Profile - Tracxn
Nov 27, 2024 Capsida. has raised a total funding of $50M over 1 round. What are the most recent funding rounds of Capsida? Its latest funding round was a Series A round on Apr 29, …See details»
Capsida Biotherapeutics - LinkedIn
Capsida Biotherapeutics Inc. is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening ...See details»
Capsida Biotherapeutics - Craft
Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary Adeno-Associated Virus (AAV) …See details»
Capsida - Updates, News, Events, Signals & Triggers - Crunchbase
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.See details»
Capsida - Funding, Financials, Valuation & Investors - Crunchbase
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Capsida Biotherapeutics Poised to Capitalize on …
THOUSAND OAKS, Calif., Dec. 7, 2021 /PRNewswire/ -- Capsida Biotherapeutics Inc., an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies ...See details»
Contact - Capsida Biotherapeutics
We harness the power of our diverse backgrounds and thoughts to deliver on our purpose. We have a sense of collective responsibility and unity.See details»
Capsida - Overview, News & Similar companies | ZoomInfo.com
Nov 10, 2023 View Capsida (www.capsida.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Capsida - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Capsida . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of Board …See details»
Capsida Biotherapeutics - Work in biotech
Capsida Biotherapeutics is developing tissue-targeted, non-invasive gene therapies for rare and common diseases. Capsida’s approach is to use an intravenous delivery of a single, …See details»
Presentations - Capsida Biotherapeutics
Capsida Company Overview. An overview presentation about our company, leadership, science, and innovation. – Download PDFSee details»
Capsida Biotherapeutics Announces Strategic Collaboration with …
Jan 4, 2023 Capsida Biotherapeutics is the only fully integrated gene therapy platform company that through IV delivery of a single engineered capsid can target single or multiple organs …See details»
Capsida Biotherapeutics to Present New Data on its Wholly …
Apr 22, 2024 Capsida Biotherapeutics ("Capsida"), a leading fully integrated targeted gene therapy company, developing treatments for rare and common diseases across all ages, today …See details»
Team - Capsida Biotherapeutics
Built through a combination of in-house R&D and industry partnerships, our therapeutic approaches – including gene replacement and gene editing – are designed to bring therapies …See details»
Publications - Capsida Biotherapeutics
Oral presentations from the American Society for Gene & Cell Therapy Annual Meeting – 2024. Systemic AAV Gene Therapy with CNS-Targeted Engineered Capsids Achieves Significant …See details»